Wells Fargo initiates coverage on Maze Therapeutics with an Overweight rating and $55 PT.

jueves, 4 de diciembre de 2025, 8:49 am ET1 min de lectura
MAZE--

Wells Fargo initiates coverage on Maze Therapeutics with an Overweight rating and $55 PT.

Wells Fargo initiates coverage on Maze Therapeutics with an Overweight rating and $55 PT.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios